'Encouraging' Real-life Data on Ranibizumab in Wet AMD'Encouraging' Real-life Data on Ranibizumab in Wet AMD

Most patients with age-related macular degeneration (AMD) in a 'real-life' study maintained their vision or continued to improve after 5 years of treatment with ranibizumab. Medscape Medical News
Source: Medscape Ophthalmology Headlines - Category: Opthalmology Tags: Ophthalmology News Source Type: news